Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Abreos Biosciences
AddedFeb 15, 2024
UpdatedJun 18, 2026
Abreos Biosciences

Abreos Biosciences

Private Equity

Abreos Biosciences, a San Diego-based biotech firm, develops assays for personalized dosing and counterfeit detection of therapeutic antibodies.

HQ
San Diego, CA, US
Founded
2013
Overview
Compare
Fundraising
Employees
Website

Abreos Biosciences, founded in San Diego, is an early-stage biotechnology company focused on developing innovative laboratory-based and point-of-care assays. Their core mission is to enhance personalized medicine by enabling precise dosing and counterfeit detection of therapeutic monoclonal antibodies. Abreos Biosciences aims to serve the healthcare market in the United States, providing critical tools for clinicians to optimize treatment outcomes and ensure the authenticity of biologic therapies.

Notable figures affiliated with Abreos Biosciences include experts in biotechnology and healthcare innovation. The company has attracted investment from key players in the biotech sector, bolstering its research and development capabilities. Abreos Biosciences has achieved significant milestones in assay development, contributing to the broader field of personalized medicine. Their impact is evident in improved patient care through tailored therapeutic approaches and enhanced drug safety.

Abreos Biosciences - Similar Companies

Abpro logo

Abpro

Abterra Biosciences logo

Abterra Biosciences

abterrabio.com

AnaBios logo

AnaBios

anabios.com

Dren Bio logo

Dren Bio

drenbio.com

Abalone Bio logo

Abalone Bio

abalonebio.com

OmniAb logo

OmniAb

omniab.com

AltruBio logo

AltruBio

RevMAb Biosciences logo

RevMAb Biosciences

revmab.com

ABio-X logo

ABio-X

abio-x.com

Amberstone Biosciences logo

Amberstone Biosciences

amberstonebio.com

Avidity Biosciences logo

Avidity Biosciences

aviditybio.com

Abwiz Bio logo

Abwiz Bio

abwizbio.com

Abacus Bioscience logo

Abacus Bioscience

Adaptive Biotechnologies logo

Adaptive Biotechnologies

Fabrus logo

Fabrus

fabrus.net

Abreos Biosciences - Quick Facts

Who are Abreos Biosciences' competitors?

Companies similar to Abreos Biosciences include Abpro, Abterra Biosciences, AnaBios and Dren Bio.

When was Abreos Biosciences founded?

Abreos Biosciences was founded in 2013.

Where is Abreos Biosciences' headquarters located?

Abreos Biosciences' headquarters is located in San Diego, CA, US.

When was Abreos Biosciences' last funding round?

Abreos Biosciences' most recent funding round was for $5.6M (USD) in September 2020.

How much has Abreos Biosciences raised to-date?

As of Sep 15, 2020, Abreos Biosciences has raised a total of $8.6M (USD).

How many employees does Abreos Biosciences have?

Abreos Biosciences has 6 employees as of Feb 5, 2024.

Abreos Biosciences - Classification

Ownership
  • Venture Capital
Technology
  • Analytics
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Biotech Assays
Tags
  • Biotech
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified